Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oragenics Inc (OGEN)
NYSE MKT:OGEN
Holding OGEN?
Track your performance easily
OGEN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.47 - $7.74
Previous Close$0.5
Volume195.10K
Average Volume (3M)716.98K
Market Cap
$4.30M
Enterprise Value$2.95M
Total Cash (Recent Filing)$1.35M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.83
Next Earnings
Aug 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.20
Shares Outstanding5,580,693
10 Day Avg. Volume761,327
30 Day Avg. Volume716,980
Standard Deviation0.32
R-Squared0.00659
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-10.02
Price to Sales (P/S)134.45
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue143.01
Enterprise Value/Gross Profit22.47
Enterprise Value/Ebitda-0.61
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oragenics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OGEN FAQ
What was Oragenics Inc’s price range in the past 12 months?
Oragenics Inc lowest stock price was $0.47 and its highest was $7.74 in the past 12 months.
What is Oragenics Inc’s market cap?
Currently, no data Available
When is Oragenics Inc’s upcoming earnings report date?
Oragenics Inc’s upcoming earnings report date is Aug 12, 2024 which is 38 days ago.
How were Oragenics Inc’s earnings last quarter?
Oragenics Inc released its earnings results on May 13, 2024. The company reported -$0.701 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.701.
Is Oragenics Inc overvalued?
According to Wall Street analysts Oragenics Inc’s price is currently Overvalued.
Does Oragenics Inc pay dividends?
Oragenics Inc does not currently pay dividends.
What is Oragenics Inc’s EPS estimate?
Oragenics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oragenics Inc have?
Oragenics Inc has 8,659,071 shares outstanding.
What happened to Oragenics Inc’s price movement after its last earnings report?
Oragenics Inc reported an EPS of -$0.701 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 48.571%.
Which hedge fund is a major shareholder of Oragenics Inc?
Currently, no hedge funds are holding shares in OGEN
---
Oragenics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-84.84%
12-Months-Change
Fundamentals
Return on Equity
-454.72%
Trailing 12-Months
Asset Growth
-67.99%
Trailing 12-Months
Company Description
Oragenics Inc
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.
---
Technical Analysis
---